TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 9.95
+0.19 (1.95%)
Jul 31, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 4.06 billion as of July 31, 2026. Its market cap has decreased by -74.11% in one year.
Market Cap
4.06B
Enterprise Value
3.52B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.95
ChartMarket Cap Chart
Since June 23, 2025, HKG:2617's market cap has decreased from 9.33B to 4.06B, a decrease of -56.48%. That is a compound annual growth rate of -52.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 4.06B | -91.10% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Bao Pharmaceuticals | 5.74B |
| CK Life Sciences Int'l., (Holdings) | 5.38B |
| Ocumension Therapeutics | 4.13B |
| Jacobio Pharmaceuticals Group | 3.70B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.64B |
| Guangzhou Innogen Pharmaceutical Group | 3.25B |
| Medtide | 3.20B |